Two Sigma Investments’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $277K | Sell |
|
|||||
|
2024
Q2 | $484K | Sell |
|
|||||
|
2024
Q1 | $5.56M | Sell |
|
|||||
|
2023
Q4 | $6.87M | Sell |
|
|||||
|
2023
Q3 | $12M | Buy |
|
|||||
|
2023
Q2 | $1.65M | Buy |
|
|||||
|
2023
Q1 | $517K | Buy |
|
|||||
|
2022
Q4 | $450K | Buy |
|
|||||
|
2022
Q3 | $457K | Sell |
|
|||||
|
2022
Q2 | $872K | Sell |
|
|||||
|
2022
Q1 | $2.65M | Sell |
|
|||||
|
2021
Q4 | $3.9M | Sell |
|
|||||
|
2021
Q3 | $3.08M | Buy |
|
|||||
|
2021
Q2 | $2.19M | Buy |
|
|||||
|
2021
Q1 | $885K | Buy |
|
|||||
|
2020
Q4 | $761K | Buy |
|
|||||
|
2020
Q3 | $424K | Sell |
|
|||||
|
2020
Q2 | $943K | Buy |
|